Clinical Trials Browser

Phase 2 × defactinib × 30 days × Clear all

NCT06007924 2026-02-19

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Phase 2 Recruiting

Thyroid Neoplasms